E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/5/2018 in the Prospect News Investment Grade Daily and Prospect News Preferred Stock Daily.

MetLife greenshoe exercise lifts series E preferreds to $805 million

New York, June 5 – MetLife, Inc.’s offering of 5.625% $25-par series E non-cumulative preferred stock was increased to $805 million through full exercise of the over-allotment option, according to an 8-K filing with the Securities and Exchange Commission.

The $105 million greenshoe was exercised on Friday and the sale settled on Monday.

MetLife originally priced $700 million of the preferreds at par of $25.00 on May 30.

The offering was increased from $200 million and came at the low end of talk for a dividend of 5.625% to 5.75%.

Morgan Stanley & Co. LLC, BofA Merrill Lynch, UBS Investment Bank and Wells Fargo Securities LLC are the joint bookrunners.

The preferreds will be callable at par after five years.

The company plans to list the preferreds on the New York Stock Exchange under the symbol “METPrE.”

MetLife is a New York City-based insurance provider.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.